GlassScriptPhysician profile
Callie Morlock
NPI 1003499476
$9,007.94
in general payments reported to CMS, 2019-2025
11 companies · $3,623 in 2025
The $3,623 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $569 · 2024: $4,817 · 2025: $3,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,749 · Food and Beverage: $3,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,749.04 |
| Food and Beverage | $3,258.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,738.86 | 2024-2025 | Truelok, Tl-Hex Truelok Hexapod System, Physio-Stim |
| Paragon 28, INC. | $2,173.66 | 2024-2025 | Portfolio |
| Trimed, INC. | $1,386.07 | 2024 | |
| Smith+Nephew, INC. | $831.08 | 2023-2024 | Grafix Pl, Stravix Pl, Stravix Mesh |
| Stryker Corporation | $645.89 | 2025 | Hoffmann, Actishield, Infinity |
| Arthrex, INC. | $538.88 | 2025 | |
| Treace Medical Concepts, INC. | $253.52 | 2025 | |
| Medtronic, INC. | $151.94 | 2025 | Intellis Adaptivestim |
| Integra Lifesciences Corporation | $136.78 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Linvatec Corporation | $128.18 | 2025 | Neospan, Ibs, Biobrace 23mm |
| Alliance Medical | $23.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callie Morlock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.